203 related articles for article (PubMed ID: 26159592)
1. 15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
Byrne K; Siva S; Chait L; Callahan J; Bressel M; Seel M; MacManus MP; Hicks RJ
J Nucl Med; 2015 Sep; 56(9):1328-33. PubMed ID: 26159592
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
Siva S; Byrne K; Seel M; Bressel M; Jacobs D; Callahan J; Laing J; Macmanus MP; Hicks RJ
J Nucl Med; 2013 Aug; 54(8):1223-9. PubMed ID: 23753187
[TBL] [Abstract][Full Text] [Related]
3. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
[TBL] [Abstract][Full Text] [Related]
5. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
[TBL] [Abstract][Full Text] [Related]
6. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
[TBL] [Abstract][Full Text] [Related]
7.
Mahajan S; Barker CA; Mauguen A; D'Angelo SP; Yeh R; Pandit-Taskar N
J Nucl Med; 2022 Jun; 63(6):906-911. PubMed ID: 34620729
[TBL] [Abstract][Full Text] [Related]
8. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Concannon R; Larcos GS; Veness M
J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
11. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
[TBL] [Abstract][Full Text] [Related]
13. Role of
Houard C; Pinaquy JB; Mesguich C; Henriques de Figueiredo B; Cazeau AL; Allard JB; Laharie H; Bordenave L; Fernandez P; Vendrely V
J Nucl Med; 2017 Sep; 58(9):1414-1420. PubMed ID: 28280225
[TBL] [Abstract][Full Text] [Related]
14. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Lamonica D; Graf DA; Munteanu MC; Czuczman MS
J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer.
Duong CP; Hicks RJ; Weih L; Drummond E; Leong T; Michael M; Thomas RJ
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):770-8. PubMed ID: 16550384
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Prognostic Value of
Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
[TBL] [Abstract][Full Text] [Related]
18. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG PET in small-cell cervical cancer: a prospective study with long-term follow-up.
Chen MY; Chou HH; Liu FY; Chen CY; Lin G; Yang LY; Pan YB; Jung SM; Wu RC; Huang YT; Tsai JC; Yen TC; Lai CH; Chang TC
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):663-74. PubMed ID: 26519293
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 18F-FDG PET/CT and 111In pentetreotide scan for detection of Merkel cell carcinoma.
Lu Y; Fleming SE; Fields RC; Coit DG; Carrasquillo JA
Clin Nucl Med; 2012 Aug; 37(8):759-62. PubMed ID: 22785503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
